Top Pharmaceutical Stocks To Follow Today – February 19th

Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson, D-Wave Quantum, and Celanese are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks refer to shares of companies that are involved in the research, development, manufacturing, and selling of pharmaceutical products. These stocks are typically part of the healthcare sector and can be influenced by factors such as clinical trial results, regulatory approvals, and market demand for specific drugs. Investors interested in this sector may focus on pharmaceutical stocks for potential growth and dividends. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE:LLY traded up $11.87 during mid-day trading on Wednesday, hitting $869.07. 1,939,692 shares of the stock traded hands, compared to its average volume of 3,743,590. The business’s 50-day moving average price is $796.41 and its 200 day moving average price is $845.73. The company has a market cap of $825.03 billion, a PE ratio of 74.35, a price-to-earnings-growth ratio of 1.35 and a beta of 0.42. Eli Lilly and Company has a 12-month low of $711.40 and a 12-month high of $972.53. The company has a quick ratio of 0.97, a current ratio of 1.27 and a debt-to-equity ratio of 2.03.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

NYSE:MRK traded up $1.06 during mid-day trading on Wednesday, hitting $84.35. 7,627,753 shares of the stock traded hands, compared to its average volume of 14,949,747. The business’s 50-day moving average price is $96.26 and its 200 day moving average price is $104.62. The company has a market cap of $213.37 billion, a PE ratio of 12.53, a price-to-earnings-growth ratio of 0.71 and a beta of 0.38. Merck & Co., Inc. has a 12-month low of $81.04 and a 12-month high of $134.63. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

NYSE:JNJ traded up $2.66 during mid-day trading on Wednesday, hitting $157.65. 3,745,039 shares of the stock traded hands, compared to its average volume of 8,887,343. The business’s 50-day moving average price is $148.12 and its 200 day moving average price is $155.85. The company has a market cap of $379.55 billion, a PE ratio of 23.71, a price-to-earnings-growth ratio of 2.50 and a beta of 0.52. Johnson & Johnson has a 12-month low of $140.68 and a 12-month high of $168.85. The company has a quick ratio of 0.86, a current ratio of 1.11 and a debt-to-equity ratio of 0.43.

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

NYSE:QBTS traded up $0.85 during mid-day trading on Wednesday, hitting $6.89. 74,365,889 shares of the stock traded hands, compared to its average volume of 85,807,750. The business’s 50-day moving average price is $6.65 and its 200 day moving average price is $3.25. The company has a market cap of $1.85 billion, a PE ratio of -16.30 and a beta of 1.10. D-Wave Quantum has a 12-month low of $0.75 and a 12-month high of $11.41.

Celanese (CE)

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.

Shares of CE traded down $16.20 during mid-day trading on Wednesday, reaching $53.71. The company’s stock had a trading volume of 9,537,400 shares, compared to its average volume of 2,411,159. The company’s fifty day moving average price is $69.16 and its two-hundred day moving average price is $98.72. Celanese has a 52 week low of $52.97 and a 52 week high of $172.16. The company has a current ratio of 1.37, a quick ratio of 0.76 and a debt-to-equity ratio of 1.47. The stock has a market cap of $5.87 billion, a PE ratio of 5.39, a P/E/G ratio of 1.36 and a beta of 1.17.